issues with glp 1 Insights from Specialty Physicians on GLP-1RA Medications Off-Label Use Adverse effects of GLP-1 class

2 CKD confirmatory secondary endpoints Significant 18% RRR of MACE with Ozempic 2 For adults with T2D and CKD, for a confirmatory secondary endpoint: Time to first occurrence of MACE (CV death, nonfatal MI, or nonfatal stroke) vs placebo when both were added to standard of care 1,2 Time to first MACE 1-3,w-z 1-3,w-z w Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as a competing risk using the Aalen-Johnson estimator

Exercise helps move stool through the digestive tract (increased gastric motility)

Holst suspects this may help explain how GLP-1 agonists influence organs that lack direct receptor expression, including parts of the central nervous system

Based on the route of administration, the South Africa diabetes drugs market is divided into oral, subcutaneous, and intravenous